liraglutide
Showing 1 - 25 of 523
Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)
Not yet recruiting
- Polycystic Ovary
- liraglutide
- Metformin
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 28, 2023
Obesity, Childhood, Neural Development Trial in New Haven (Liraglutide)
Completed
- Obesity, Childhood
- Neural Development
- Liraglutide
-
New Haven, ConnecticutYale University
Dec 5, 2022
Type2 Diabetes, Coronary Artery Disease Trial in Miami (Liraglutide Pen Injector [Victoza], matching liraglutide- pre-filled
Recruiting
- Type2 Diabetes
- Coronary Artery Disease
- Liraglutide Pen Injector [Victoza]
- matching liraglutide-placebo pre-filled pens
-
Miami, FloridaUniversity of Miami
Nov 4, 2022
Parkinson Disease Trial in Los Angeles (Liraglutide, Placebo)
Completed
- Parkinson Disease
- Liraglutide
- Placebo
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Oct 27, 2022
Polycystic Ovary Syndrome, Obesity, Infertility, Female Trial (Liraglutide + Metformin, Metformin)
Not yet recruiting
- Polycystic Ovary Syndrome
- +2 more
- Liraglutide + Metformin
- Metformin
- (no location specified)
Jul 10, 2023
Obesity, Status Post Sleeve Gastrectomy Trial run by the NICHD (Liraglutide)
Recruiting
- Obesity
- Status Post Sleeve Gastrectomy
- Liraglutide
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 16, 2022
Diabetes, Type 1 Trial in Monterrey (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 1
- Liraglutide
-
Monterrey, Nuevo León, MexicoCentro Médico Nacional del Noreste Hospital de Especialidades UM
Jul 19, 2022
Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)
Not yet recruiting
- Growth Hormone Deficiency
- Healthy
- growth hormone and lirglutide
- +3 more
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022
Obesity Trial in Rochester (Liraglutide, Placebo)
Completed
- Obesity
- Liraglutide
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
May 27, 2022
Type 2 Diabetes Trial in Shanghai (Liraglutide injection,RD12014, Liraglutide injection,Victoza)
Completed
- Type 2 Diabetes
- Liraglutide injection,RD12014
- Liraglutide injection,Victoza
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Mar 16, 2022
Diabetes, Type 2 Trial in Palermo (Liraglutide injection, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Liraglutide injection
- Insulin Glargine
-
Palermo, ItalyInternal Medicine Ward, University of Palermo
May 3, 2022
Type 1 Diabetes Trial in Kuwait City (drug, other, procedure)
Not yet recruiting
- Type 1 Diabetes
- Liraglutide / Semaglutide
- +4 more
-
Kuwait City, Al Asimah, KuwaitDasman Diabetes Institute
Jan 8, 2023
Healthy Trial in Mannheim (BI 1820237, Placebo, Saxenda®)
Active, not recruiting
- Healthy
- BI 1820237
- +3 more
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Aug 10, 2022
Morbid Obesity Trial in Alexandria (Liraglutide Pen Injector [Saxenda])
Not yet recruiting
- Morbid Obesity
- Liraglutide Pen Injector [Saxenda]
-
Alexandria, EgyptMadina Women's Hospital
Mar 9, 2022
Overweight AF Patients Following Ablation WithPotential Weight
Not yet recruiting
- Atrial Fibrillation
- +3 more
- Liraglutide plus upstream risk factors modification advice and consultation
- (no location specified)
Nov 1, 2022
Obese, Overweight Trial in Shanghai (Liraglutide, Placebo)
Active, not recruiting
- Obese
- Overweight
- Liraglutide
- Placebo
-
Shanghai, ChinaZhongshan Hosital, Fudan University
Apr 16, 2022
Type 2 Diabetes Trial in Chongqing (Liraglutide, Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation),
Completed
- Type 2 Diabetes Mellitus
- Liraglutide
- Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
-
Chongqing, Chongqing, ChinaThe third hospital affiliated to the Third Military Medical Univ
Apr 30, 2022
Type 1 Diabetes Trial in Buffalo (Liraglutide)
Active, not recruiting
- Type 1 Diabetes
- Liraglutide
-
Buffalo, New YorkUBMD Pediatrics, Division of Pediatric Endocrinology
Mar 7, 2022
Type 2 Diabetes Trial in Helsinki (Liraglutide, Placebo)
Completed
- Type 2 Diabetes
- Liraglutide
- Placebo
-
Helsinki, FinlandHelsinki University Central Hospital
Apr 11, 2022
Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)
Completed
- Type 2 Diabetes Treated With Insulin
- +2 more
- Dulaglutide
- Liraglutide
-
Lahore, Punjab, PakistanZainab Khan
Mar 11, 2022
Pouchitis, Irritable Pouch Syndrome Trial in Chapel Hill (Liraglutide Pen Injector, Placebo Pen Injector)
Recruiting
- Pouchitis
- Irritable Pouch Syndrome
- Liraglutide Pen Injector
- Placebo Pen Injector
-
Chapel Hill, North CarolinaUniversity of North Carolina
Mar 23, 2022
Diabete Type 2 Trial (Liraglutide, Placebo)
Not yet recruiting
- Diabete Type 2
- Liraglutide
- Placebo
- (no location specified)
Feb 24, 2022
Bipolar Disorder, Obesity Trial in Mason (LIRAGLUTIDE, Placebo)
Active, not recruiting
- Bipolar Disorder
- Obesity
- LIRAGLUTIDE
- Placebo
-
Mason, OhioLindner Center of HOPE
May 24, 2022
Therapeutic Equivalency Trial in Qingdao (Liraglutide injection, Liraglutide injection(Victoza®))
Completed
- Therapeutic Equivalency
- Liraglutide injection
- Liraglutide injection(Victoza®)
-
Qingdao, Shandong, ChinaPhase I Clinical Research Center
Feb 4, 2022